| Identification | Back Directory | [Name]
4-(3-(2H-1,2,3-Triazo-2-yl)phenylaMino)-2-((1R,2S)-2-aMinocyclohexylaMino) pyriMidine-5-carboxaMide | [CAS]
1370261-96-3 | [Synonyms]
P505-15
PRT-2607
BIIB-057
PRT062607
P505-15 HCl
p50515/p505-15
P 505-15 - PRT 062607
PRT062607;P505-15;BIIB-057
P505-15 (PRT062607,BIIB057)
4-(3-(2H-1,2,3-Triazo-2-y...
P505-15, PRT062607,PRT-2607, BIIB-057
4-(3-(2h-1,2,3-triazo-2-yl)phenylamino)-2-((1r,2s)-2-aminocy...
4-(3-(2H-1,2,3-Triazo-2-yl)phenylaMino)-2-((1R,2S)-2-aMinocyclohexylaMino) pyriMidine-5-carboxaMide
4-((3-(2H-1,2,3-Triazol-2-yl)phenyl)amino)-2-(((1R,2S)-2-aminocyclohexyl)amino)pyrimidine-5-carboxamide
2-[[(1R,2S)-2-Aminocyclohexyl]amino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]amino]-5-pyrimidinecarboxamide
5-Pyrimidinecarboxamide, 2-[[(1R,2S)-2-aminocyclohexyl]amino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]amino]-
4-(3-(2H-1,2,3-Triazo-2-yl)phenylaMino)-2-((1R,2S)-2-aMinocyclohexylaMino) pyriMidine-5-carboxaMide acetate | [Molecular Formula]
C19H23N9O | [MOL File]
1370261-96-3.mol | [Molecular Weight]
393.45 |
| Chemical Properties | Back Directory | [Boiling point ]
707.6±70.0 °C(Predicted) | [density ]
1.54±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMF: 50 mg/ml; DMF:PBS (pH 7.2) (1:1): 0.5 mg/ml; DMSO: 25 mg/ml; Ethanol: 10 mg/ml | [form ]
A crystalline solid | [pka]
14.05±0.50(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
2-[[(1R,2S)-2-Aminocyclohexyl]amino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]amino]-5-pyrimidinecarboxamide is a highly selective spleen tyrosine kinase (Syk) inhibitor that is used in the treatment of leukemia. |
|
| Company Name: |
SPIRO PHARMA
|
| Tel: |
|
| Website: |
www.spiropharma.com.cn |
|